Boxer Capital LLC 13D and 13G filings for Bellicum Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 4:37 pm Sale | 2020-12-31 | 13G | Bellicum Pharmaceuticals, Inc. BLCM | Boxer Capital LLC | 265,743 4.990% | -247,617 (-48.23%) | Filing |